Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Total Liabilities (2017 - 2021)

Historic Total Liabilities for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $18.1 million.

  • Cogent Biosciences' Total Liabilities fell 2379.05% to $18.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $18.1 million, marking a year-over-year decrease of 2379.05%. This contributed to the annual value of $16.2 million for FY2020, which is 799.5% down from last year.
  • As of Q3 2021, Cogent Biosciences' Total Liabilities stood at $18.1 million, which was down 2379.05% from $15.7 million recorded in Q2 2021.
  • In the past 5 years, Cogent Biosciences' Total Liabilities ranged from a high of $32.0 million in Q1 2019 and a low of $10.8 million during Q1 2021
  • For the 5-year period, Cogent Biosciences' Total Liabilities averaged around $21.6 million, with its median value being $22.3 million (2017).
  • As far as peak fluctuations go, Cogent Biosciences' Total Liabilities plummeted by 6002.03% in 2020, and later skyrocketed by 3299.48% in 2021.
  • Quarter analysis of 5 years shows Cogent Biosciences' Total Liabilities stood at $20.8 million in 2017, then grew by 23.46% to $25.7 million in 2018, then crashed by 31.26% to $17.7 million in 2019, then decreased by 8.0% to $16.2 million in 2020, then grew by 11.68% to $18.1 million in 2021.
  • Its last three reported values are $18.1 million in Q3 2021, $15.7 million for Q2 2021, and $10.8 million during Q1 2021.